Evidence mapPaperPMID 41583299Full record

ReviewCureus2025

Oral Glucose Tolerance Test for Everyone: Affordable, Accessible, and Well-Tolerated Alternatives to Traditional Glucose Liquid.

Andrew El Alam, Mohamad Fleifel, Abd Al Latif Awdi, Khaled Abi Farraj, Amal Al Zoghbi, Bertha Maria Nassani, Raoul Al Kassis, Hicham Baba, Soha Bayda, Assem Al Hariri and 1 more

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrew El AlamDepartment of Endocrinology, Lebanese American University Medical Center, Beirut, LBN.
Mohamad FleifelDepartment of Endocrinology, American University of Beirut Medical Center, Beirut, LBN.
Abd Al Latif AwdiDepartment of Endocrinology, Beirut Arab University Medical Center, Beirut, LBN.
Khaled Abi FarrajDepartment of Endocrinology, Lebanese American University Medical Center, Beirut, LBN.
Amal Al ZoghbiDepartment of Endocrinology, Lebanese American University Medical Center, Beirut, LBN.
Bertha Maria NassaniDepartment of Internal Medicine and Clinical Immunology, Hospital Hôtel Dieu de France, Beirut, LBN.
Raoul Al KassisDepartment of General Medicine, Lebanese University Faculty of Medicine, Beirut, LBN.
Hicham BabaDepartment of Endocrinology, Lebanese American University Medical Center, Beirut, LBN.
Soha BaydaDepartment of Endocrinology, Lebanese American University Medical Center, Beirut, LBN.
Assem Al HaririDepartment of Endocrinology, Louis Pasteur Hospital Center, Chartres, FRA.
Arnaud MonierDepartment of Endocrinology, Louis Pasteur Hospital Center, Chartres, FRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing global burden of diabetes requires innovative strategies for accurate and patient-friendly diagnostic methods. The oral glucose tolerance test (OGTT), a long-standing cornerstone in diabetes screening, employs a glucose solution called Glucola. However, the drawbacks of Glucola, including discomfort, side effects, and cost, have fuelled the exploration of alternative substances for OGTT. This comprehensive review article examines the clinical significance, patient acceptance, and cost-effectiveness of these emerging alternatives. An extensive literature search in PubMed and Google Scholar was done for articles published after 1995, but priority was given to articles published after the year 2000. Twelve articles discussing alternatives to Glucola were included in this review. Research consistently indicates that these alternatives offer diagnostic accuracy comparable to that of Glucola while mitigating patient discomfort and reducing financial burdens. The economic aspect of diabetes detection is a key consideration, given the substantial costs associated with Glucola-based testing protocols. By synergizing alternative approaches with patient education, diabetes screening can be made more accessible and cost-effective. The present article reviewed the available clinical data on alternatives explored for oral glucose tolerance testing (OGTT) beyond the use of Glucola, shedding light on their accuracy and tolerance in different population groups.

Indexed as

alternativescost effectivenessdiabetesdiagnosisglucolaogttscreeningtolerance

Identifiers

PMID41583299
PMCPMC12829513

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.